Turn against ALS: the first drug that fights it approved in the United States
A medicine against ALS gives new hope in the fight against the disease. To report it in Italy Giovanni d ’ Agata president of the “Rights Desk” Association always committed also to disseminating the most recent scientific discoveries for the sick and patients. For the first time, for the first time, in the United States, a new drug against amyotrophic lateral sclerosis (SLA), also called Lou Gehrig disease: the Food and Drug Administration (FDA) has approved for the first time for the first time for 20 years, in the Based on the Edaravone.
SLA The disease of Stephen Hawking
Initially developed in Japan for the treatment of strokes, the product has been experienced
in the US on 137 patients affected by the lateral amyotrophic sclerosis: the sick who received the
drug have highlighted a decisive slowdown in the progression of the disease, which leads to
Complete paralysis until death. “We are pleased that these patients now have a ’ more option ’”, ha
declared Eric Bastings of the FDA.
Administered for daily intravenous infusions for two consecutive weeks and then at intervals of
Two weeks, however, the drug has risks of serious side effects, including anaphylactic shock and
breath difficulties. The medicine has a very high market price, 1.000 dollars by infusion, but
l ’ manufacturer – Mitsubishi Tanabe Pharma America is working with the American government
so that the sick get discounts and aid.